Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4c49a32b11d462f381f770148f7e5ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de12bdfa1e324d9202239cce9d029460 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36121 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N7-022 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
filingDate |
2017-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acd9cec35fe69a3ad3ebdeeb906002a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c4fd067664b7f31732fc1f4bd625387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e78458e5bd32edd3e821c26ee54df05b |
publicationDate |
2019-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3538211-A1 |
titleOfInvention |
Treatment of diseases mediated by thyroid and parathyroid hormones |
abstract |
Modulation of neural activity in the superior laryngeal nerve (SLN) or cervical sympathetic trunk (CST) is effective in treating diseases and conditions mediated by thyroid and parathyroid hormones, in particular diseases associated with calcitonin secretion (e.g. osteoporosis) or diseases associated with thyroxine secretion (e.g. hypothyroid syndrome). |
priorityDate |
2016-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |